Funding has now been discontinued for the National Clinical Evidence Taskforce and the COVID-19 guidelines as of 30 June 2023.
These guidelines are no longer continually updated but will remain online until the guidance becomes inaccurate and/or no longer reflects the evidence or recommended practice.
For three years, the COVID-19 guideline delivered trusted, up-to-date clinical guidelines and flowcharts for everyone throughout the COVID-19 pandemic.
The Taskforce provided a successful model of rapid evidence surveillance, while implementing a world-first, cross-disciplinary collaboration, including healthcare workers, evidence experts, consumers and 35 peak health bodies across Australia.
Evidence-based clinical COVID-19 guidelines updated with the latest research
We will revise and add recommendations each week as our evidence teams and expert panels identify priority clinical questions and synthesise new research.
Flowcharts incorporating living guideline recommendations and guidance issued or endorsed by Taskforce members
Cochrane’s COVID-19 Study Register is a freely-available, continually-updated, annotated reference collection of human studies on COVID-19, including interventional, observational, diagnostic, prognostic, epidemiological, and economic designs.
The ANZCTR is an online registry of clinical trials being undertaken in Australia, New Zealand and elsewhere. A list of coronavirus/COVID-19 studies currently recruiting in Australia is available here.
The COVID-19-COS project is an international initiative bringing together patients, the public and health professionals to identify, prioritise and agree on the most important outcomes for research in COVID-19.
